APR 9, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Doxycycline Hyclate (Labeling)
U.S. Food and Drug Administration
FDA supplemental approval for labeling changes to doxycycline hyclate delayed-release tablets; regulatory action without clinical trial data.
Reported
Approval date2026-04-09
Product strengths75 mg and 100 mg base equivalent